☆ 4.7 Letter

Smoking and immunotherapy efficacy in lung cancer by PDL1 subgroups: An individual participant data meta-analysis of atezolizumab clinical trials Smoking and immunotherapy efficacy in lung cancer

EUROPEAN JOURNAL OF CANCER (2022)

Get Full Text
Add to Collection

Journal

EUROPEAN JOURNAL OF CANCER
Volume 160, Issue -, Pages 279-281

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.ejca.2021.10.020

Keywords

Atezolizumab; Non-small cell lung cancer; Smoking

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.